Navigation Links
MonoFluo Legionella pneumophilia IFA Test

ProductsMonoFluo Legionella pneumophilia IFA Test
Company Bio-Rad Laboratories
Item MonoFluo Legionella pneumophilia IFA Test
Features 
  • Ready-to-use reagents and slides
  • Monoclonal antibodies react to all known serogroups of L. pneumophilia
  • Rapid turnaround time
Description The Monofluo Legionella pneumophilia IFA Test kit is a user-friendly indirect immunofluorenscence assay with ready-to-use reagents in dropper bottles. A single monoclonal antibody is used to detect and identify all serogroups of L. pneumophilia directly in patient specimens or in culture isolates, confirming a diagnosis of Legionnaires disease.
Info Bio-Rad Laboratories
Customer Service: 1-800-2-BIORAD
Web site: http://www.bio-rad.com

Related medicine products :

1. Legionella IgG/M II ELISA
2. Legionella Urinary Antigen ELISA
3. Probe Tec ET Legionella pneumophila DNA Amplified Assay
4. OnarLp-QP: Legionella diagnostic for real-time PCR
5. Legionella pneumophila IgG/IgM
6. OnarLp: Legionella diagnostic for conventional PCR
7. NOW® Legionella
8. Legionella Latex Test
9. Legionella IgG/M II
10. Legionella Urinary Antigen (Binax)
11. Legionella Antibody (Indirect) Test Kits Groups 1-4
StreamLAB combines consolidated analytical testing of Dimension Systems with pre- and post-analytical functions to provide an innovative laboratory automation solution "REAL-ized" for the needs of to
Roche OMNI S is the next generation Critical Care Analyzer completes and extends the Roche product portfolio for Hospital Point of Care applications. The modular concept allows to customize the compr
Mini-flatbed agitator.
...range of storage capacities. Delrin rollers and gl...smoothly, eliminating the need for ball bearings w...rated drawers with non-slip textured coating provi...,i.Series platelet agitators feature a built-in ...
Medicine Products:
(Date:7/25/2008)...Authority offers patients consumers tips and encou...t safety, HARRISBURG, Pa., July 25 /PRNewswire-US...rity today supports "National Patient Safety Day" ...nd their families to,participate fully in their he...ng they can about their surgery or illness., "We ...
(Date:7/25/2008)...vanCotter Releases Results of Fourth Annual Physic...rvey, DETROIT, July 25 /PRNewswire/ -- Sullivan, ...th annual survey of physician on-call pay rates an... Report. The survey report,with data from 132 hea...an,on-call pay practices and rates paid for 33 phy...
(Date:7/25/2008)...d Relationship Based on Significant Improvements i...-- MDdatacor, Inc., a leader in health,care qualit...ers, today,announced it has entered into a long-te...pport Wellmark,s Collaboration on Quality(SM) Ince...ration between Wellmark and,primary care clinician...
(Date:7/25/2008)...TON, July 25 /PRNewswire/ -- The Elekta Family of ...r treatment solutions at the 2008,American Associa...ng,demonstrating how the joint forces of Elekta, ...n therapy planning and delivery solutions that,str...xperience for,patients, as well as enhance clinici...
Breaking Medicine News(10 mins):Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3
...in January 2007 issue of CANCER, chemotherapy is l...gnitive areas of the brain. In CANCER// (http://ww...-reviewed journal of the American Cancer Society, ...t within 12 months of receiving adjuvant chemother...
...ve observed an alarming trend in the kids, even th... like teenagers. The physical and// behavioral cha...howing up in kids between the age of 8 to 12; so t...he bill. Some of the tweens are showing a fancy t...
... Australia to study the attitudes of people toward... of Australians are concerned about the// outcome ...rchers from the University of Sydney found that ,m... being stashed away by hospitals. Many fear that t...
...halogram (EEG) to look for a connection between br...nces in emotionality and alcoholism.// The results...sue of Alcoholism: Clinical & Experimental Researc...of activities in the left and right frontal areas ...
Other Medicine News:Health News:Banking (T)issues : cloning issue surfaces 2Health News:A New Research Explores Connection Between Emotionality And Alcoholism 2Health News:A New Research Explores Connection Between Emotionality And Alcoholism 3
(Date:7/24/2008)...NTAIN VIEW, Calif., July 24 /PRNewswire-FirstCall/...announced today that it has initiated,its second P...apine).,AZ-004 is an inhalation product candidate ...on in patients with schizophrenia or bipolar disor...e and rapid pharmacokinetic,(PK) properties result...
(Date:7/24/2008)...HINGTON, July 24 /PRNewswire-USNewswire/ -- Headli...ot tell the whole story. The small scale,prelimin...e in Human,Reproduction, is based on recollected i...ning soyfoods. "This study is confounded by many,i...th a great deal of,caution," warned Dr. Tammy Hedl...
(Date:7/24/2008)...olutionary thermometer designed to take body tempe...July 24 /-- Kidz-Med, Inc.,...Pink Sheets: ASFX),United States distributor of t...is pleased to announce the results of a clinical s...the University of Milan, in,Milan, Italy, which pr...
(Date:7/24/2008)...HIA ANTIPOLIS, France, July 24 /PRNewswire-FirstCa...unced the top-line results from the 52-week,open l... the completion of,the 301 phase 3 study for napro...findings and efficacy was maintained for the one-y...ents, global assessment scale. In,addition, the re...
Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6Soyfoods Do Not Impact Sperm Count 2Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4AARP Calls on Governor Schwarzenegger to Discourage Veto of SCHIP Expansion Bill 2155 1AARP Calls on Governor Schwarzenegger to Discourage Veto of SCHIP Expansion Bill 2155 2Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless States SafeMinds 398 1Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless States SafeMinds 398 2ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 2151 1ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 2151 2ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 2151 3ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 2151 4ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 2151 5TriWest On Deck to Support Fleet Week San Diego 2148 1TriWest On Deck to Support Fleet Week San Diego 2148 2